These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20418469)

  • 1. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
    Sabattini S; Bettini G
    Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of KIT receptor in feline cutaneous mast cell tumors.
    Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
    Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical characterization of feline mast cell tumors.
    Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
    Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
    Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
    Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
    Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
    Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
    Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
    J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
    Roels S; Tilmant K; Ducatelle R
    J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in canine and feline meningioma.
    Mandara MT; Pavone S; Mandrioli L; Bettini G; Falzone C; Baroni M
    Vet Pathol; 2009 Sep; 46(5):836-45. PubMed ID: 19276056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Minichromosome Maintenance Protein 7 and c-KIT as Prognostic Markers in Feline Cutaneous Mast Cell Tumours.
    Dobromylskyj MJ; Rasotto R; Melville K; Smith KC; Berlato D
    J Comp Pathol; 2015 Nov; 153(4):244-50. PubMed ID: 26385324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
    Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
    Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of c-KIT protein in feline soft tissue fibrosarcomas.
    Smith AJ; Njaa BL; Lamm CG
    Vet Pathol; 2009 Sep; 46(5):934-9. PubMed ID: 19429996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous mast cell tumor with epitheliotropism in 3 dogs.
    Oliveira FN; Elliott JW; Lewis BC; Mathews GG; Brown RM; Treadway CM; Langohr IM
    Vet Pathol; 2013 Mar; 50(2):234-7. PubMed ID: 22700850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog.
    Preziosi R; Sarli G; Paltrinieri M
    J Comp Pathol; 2004; 130(2-3):143-51. PubMed ID: 15003472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
    Preziosi R; Morini M; Sarli G
    J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
    Brustmann H
    Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
    Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
    BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous mast cell neoplasia in cats: 14 cases (1975-1985).
    Buerger RG; Scott DW
    J Am Vet Med Assoc; 1987 Jun; 190(11):1440-4. PubMed ID: 3112049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.